Partner to teams delivering traditional and innovative customer and patient experiences, leading investment dialogue for the development of Integrated Customer Experience capabilities such as Next Best Action, Simplified Web Experience, and other infrastructure to enhance competitiveness in the pharma US commercial and medical operations.

Lead funding dialogue, including value and impact assessments, across organizations collaborating in the development of Digital Health and Cancer Detection solutions; define financial guidelines to facilitate portfolio management and prioritization; advice business development strategies - Alliance Manager for Digital Health partnerships

• Recommended revenue recognition, cost ownership, statutory reporting, among others, for (i) testing services to Biopharma partners and (ii) a multi-divisional tumor CGP assay as finance lead for product in partnership with commercial, legal and accounting teams; led cross-unit finance training program team with 3 launched courses and 1000+ trainees in first year

Assignemts in multiple geographies and business areas: Pharmaceuticals, Diagnostics and Group Functions.• Global Project Lead –Product Development Finance (Switzerland HQ): Built tool to synthesize complex functional demand data on upcoming portfolio decisions for risk management at the Late Stage LT.• Internal Auditor (Switzerland HQ): Defined action plans with Country and Region Europe senior management to reinforce compliance measures in national contracts protecting market share.• Finance Project Lead – Roche Diagnostics Vietnam: Streamlined deal approval process, fast-tracking 20% of tenders; led renewal of a three-year national distribution agreement yielding savings of 2% of sales.• Mergers & Acquisitions Manager (Switzerland HQ): Accountable for acquisition and divestment activities including valuation, due diligence and communication to buyers / sellers and internal stakeholders in two successful deals; prepared analyses for Roche’s C-suite and BoD conducing to two acquisitions, a manufacturing site divestment and a mapping of strategic early-stage targets.• Business Planning Lead- Roche France: Led multi-year planning process for €1.3Bn market, designed KPIs and improvement plans with brand teams; finance lead for the €35m French overseas territories business.• Global Alliance Controller – Genentech (South San Francisco HQ): Oversaw $1Bn/yr profit-share and royalty agreements, managing relationships with Biopharma counterparts and internal cross-functional teams; designed settlement proposals to restructure a co-promotion agreement.

• Developed and maintained 3-statement financial model consolidation for 10+ companies; headed team that built business cases to optimize profitability across different business lines and geographies, propose models to shift to renewables, screen acquisition targets, define rolling stock replacement, etc.; and prepared translation of financial statements from GAAP to IFRS, maintaining P&L stability

• Coordinated multi-market IPOs and bond offerings for ~$2Bn, achieved cash injections for ~$100m via leasebacks and deployed hedged cross-currency debt strategy reducing interest payments by $8m